Science
Longtime NIH contractor named director of infectious disease institute
Publication: Latest News from Science Magazine
Author: Jon Cohen
Source published: 16/11/2026, 22:42:24 UTC
Briefing created: 16/11/2026, 23:59:16 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/11/2026, 22:42:24 UTC.
Briefings
An NIH contractor named John Powers III, who has served as acting director of NIAID since June 2026, is set to become the permanent chief of the institute. This transition marks a shift in priorities away from HIV and biodefense, with the new role focused on other areas. The appointment follows a period of uncertainty regarding the institute's leadership structure.
Key points
- John Powers III, a physician, has served as acting director of NIAID since June 2026.
- Powers III is appointed permanent chief, signaling a shift from HIV and biodefense priorities.
Context
The National Institute of Allergy and Infectious Diseases (NIAID) is a major NIH research center. The appointment of a physician contractor as permanent chief indicates a strategic realignment of the institute's focus, potentially moving away from its current emphasis on HIV and biodefense research.
Limitations
The evidence is a single sentence from a 2026 article. It does not specify the exact date of the permanent appointment, the specific new research priorities, or the institute's total budget. The transition from acting to permanent status is described but the timeline of the change is not fully detailed.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/11/2026, 23:59:16 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiffrtad563b7dhfbxuzgmowaetuqf67lknfq6dyg6c5hvfoa6pggy